Hikma Pharmaceutical | HIK - 税引前利益





税引前利益 変化する 日付
Almirall EUR 30.32M 22M 2025-12
argenx SE USD 403.29M 17.24M 2025-12
AstraZeneca USD 3.91B 1.28B 2026-03
Autolus Therapeutics Ltd USD -91.52M 12.93M 2025-12
Bayer EUR -3.37B 2.21B 2025-12
Fresenius EUR 601M 122M 2025-12
Genmab DKK 55M 427M 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lakefront Biotherapeutics EUR 13.96M 769.2M 2026-03
Lonza CHF 624M 197M 2024-12
Merck EUR 401M 886.1M 2025-12
Orion EUR 113.4M 213.6M 2026-03
Recordati EUR 151.97M 7.02M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06